21659-1-AP

antibody from Proteintech Group

Targeting: KCNA5 HK2, HPCN1, Kv1.5

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

21659-1-AP

Provider

Proteintech Group

Product name

KCNA5 antibody

Antibody type

Polyclonal

Description

KCNA5 antibody (Cat. #21659-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Salidroside treatment decreases the susceptibility of atrial fibrillation in diabetic mice by reducing mTOR-STAT3-MCP-1 signaling and atrial inflammation.

Ren W, Huang Y, Meng S, Cao Z, Qin N, Zhao J, Huang T, Guo X, Chen X, Zhou Z, Zhu Y, Yu L, Wang H
International immunopharmacology 2024 Dec 5;142(Pt B):113196

---

Anthracycline-Induced Atrial Structural and Electrical Remodeling Characterizes Early Cardiotoxicity and Contributes to Atrial Conductive Instability and Dysfunction.

Tan R, Cong T, Xu G, Hao Z, Liao J, Xie Y, Lin Y, Yang X, Li Q, Liu Y, Xia YL
Antioxidants & redox signaling 2022 Jul;37(1-3):19-39

---

Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats.

Xu C, Zhao Z, Yuan W, Fengping Z, Zhiqiang Y, Xiaoqin Z
Clinical and experimental hypertension (New York, N.Y. : 1993) 2022 Apr 3;44(3):199-207

---

Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis.

Tsai FC, Lin YC, Chang SH, Chang GJ, Hsu YJ, Lin YM, Lee YS, Wang CL, Yeh YH
International journal of cardiology 2016 Nov 1;222:104-112